Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 05, 2023

SELL
$323.56 - $373.36 $184,429 - $212,815
-570 Reduced 94.21%
35 $13,000
Q4 2022

Feb 08, 2023

SELL
$248.67 - $334.17 $118,118 - $158,730
-475 Reduced 43.98%
605 $199,000
Q3 2022

Oct 19, 2022

SELL
$263.81 - $337.27 $22,423 - $28,667
-85 Reduced 7.3%
1,080 $285,000
Q2 2022

Jul 21, 2022

BUY
$301.4 - $428.42 $25,618 - $36,415
85 Added 7.87%
1,165 $365,000
Q3 2021

Nov 10, 2021

SELL
$396.76 - $455.92 $61,497 - $70,667
-155 Reduced 12.55%
1,080 $446,000
Q2 2021

Aug 02, 2021

SELL
$372.36 - $412.07 $214,107 - $236,940
-575 Reduced 31.77%
1,235 $489,000
Q1 2021

Apr 30, 2021

SELL
$357.26 - $392.57 $488,374 - $536,643
-1,367 Reduced 43.03%
1,810 $695,000
Q4 2020

Feb 11, 2021

SELL
$319.05 - $363.32 $501,865 - $571,502
-1,573 Reduced 33.12%
3,177 $1.15 Million
Q3 2020

Nov 12, 2020

SELL
$280.08 - $347.78 $268,876 - $333,868
-960 Reduced 16.81%
4,750 $1.6 Million
Q2 2020

Aug 11, 2020

SELL
$270.93 - $320.3 $13,004 - $15,374
-48 Reduced 0.83%
5,710 $1.62 Million
Q2 2019

Jul 23, 2019

SELL
$279.29 - $336.89 $83,787 - $101,067
-300 Reduced 4.95%
5,758 $1.94 Million
Q1 2019

Apr 29, 2019

SELL
$246.18 - $297.25 $230,178 - $277,928
-935 Reduced 13.37%
6,058 $1.79 Million
Q4 2018

Jan 17, 2019

SELL
$232.7 - $281.66 $68,646 - $83,089
-295 Reduced 4.05%
6,993 $1.78 Million
Q2 2018

Aug 03, 2018

BUY
$217.98 - $237.23 $179,397 - $195,240
823 Added 12.73%
7,288 $1.72 Million
Q1 2018

Apr 19, 2018

SELL
$218.74 - $251.43 $8,749 - $10,057
-40 Reduced 0.61%
6,465 $1.48 Million
Q4 2017

Jan 30, 2018

SELL
$217.88 - $244.43 $10,894 - $12,221
-50 Reduced 0.76%
6,505 $1.42 Million
Q3 2017

Oct 18, 2017

BUY
$231.6 - $253.39 $1.52 Million - $1.66 Million
6,555
6,555 $1.55 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Arcadia Investment Management Corp Portfolio

Follow Arcadia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arcadia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Arcadia Investment Management Corp with notifications on news.